Paternal cytokine administration alters sperm small ncRNAs and offspring brain and behavior.

Publication date: Jun 19, 2026

Paternal pre-conceptual exposure to pathogenic infection can alter offspring phenotypes via changes to sperm epigenetics, including small non-coding RNAs (ncRNAs). This phenomenon occurs even in the absence of infection when pathogen mimetics trigger paternal immune activation (PIA). While this implicates a shared component of the immune response, the specific mechanisms responsible remain unknown. Cytokines are a key component of innate immunity and are highly upregulated following exposure to both pathogens and their mimetics. Here we investigate whether paternal administration of the pro-inflammatory cytokines interleukin-1β (IL-1β) and tumor necrosis factor-α (TNF-α) recapitulates alterations to sperm small ncRNAs and offspring phenotypic changes from other models of PIA. C57BL/6J male mice were administered a single dose of IL-1β, TNF-α, or vehicle, prior to mating with nacEFve female mice, to produce offspring. Offspring from IL-1β-treated fathers exhibited altered fasting responses and female-specific alterations to stress-coping behavior. In response to paternal TNF-α, male offspring showed increased anxiety-like behavior. Analysis of paternal sperm small ncRNA revealed that IL-1β significantly downregulated several transfer RNA-derived small RNAs (tsRNAs) and P-element-induced wimpy testis (PIWI)-interacting RNA (piRNA) clusters. Surprisingly, paternal TNF-α only slightly altered small ncRNAs, downregulating a single piRNA cluster. These results partially recapitulate offspring phenotypic changes following paternal exposure to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, in a COVID-19 mouse model) and polyinosinic:polycytidylic acid (poly I:C, a viral mimetic). Ultimately, we provide the first evidence that cytokines have intergenerational effects on brain and behavior, and that they contribute to altered offspring phenotypes in viral-like PIA. This study demonstrates that paternal cytokines are causally involved in a mechanism of epigenetic inheritance following PIA, and highlights the importance of PIA as a pre-conceptual factor that may modulate offspring health, including risk of neuropsychiatric disorders.

Open Access PDF

Concepts Keywords
Coronavirus Administration
Mice Altered
Neuropsychiatric Behavior
Pathogenic Brain
Sperm Cytokines
Exposure
Il
Ncrnas
Offspring
Paternal
Pia
Pre
Small
Sperm
Tnf

Semantics

Type Source Name
disease MESH infection
disease MESH anxiety
disease MESH ncRNA
disease MESH severe acute respiratory syndrome
disease MESH COVID-19
disease MESH Psychiatric disorders
disease MESH metabolic diseases
disease MESH cancers
pathway REACTOME DNA methylation
pathway REACTOME Fertilization
disease MESH Syndrome
drug DRUGBANK Coenzyme M
disease MESH viral infection
disease MESH LPS
drug DRUGBANK Tretinoin
disease MESH melanoma
pathway KEGG Melanoma
disease MESH fever
disease MESH weight loss
drug DRUGBANK Water
pathway REACTOME Reproduction
disease MESH bacterial infections
drug DRUGBANK 3 7 11 15-Tetramethyl-Hexadecan-1-Ol
disease MESH ARC
drug DRUGBANK Phosphate ion
disease MESH PBS
drug DRUGBANK Human Serum Albumin
disease MESH CAS
disease MESH body weight
drug DRUGBANK Tricyclazole
drug DRUGBANK Saccharin
drug DRUGBANK Ethanol
disease MESH bite
disease MESH glass
disease MESH anhedonia
drug DRUGBANK Pentobarbital
drug DRUGBANK Potassium Chloride
drug DRUGBANK Sodium bicarbonate
drug DRUGBANK Sodium lauryl sulfate
drug DRUGBANK Isopropyl Alcohol
drug DRUGBANK Ademetionine
drug DRUGBANK Aspartame
disease MESH underweight
drug DRUGBANK Proline
drug DRUGBANK Trestolone
drug DRUGBANK Glutamic Acid
drug DRUGBANK L-Lysine
drug DRUGBANK Alpha-Linolenic Acid
drug DRUGBANK L-Valine
disease MESH 3’CCA
pathway REACTOME Translation
disease MESH inflammation
pathway REACTOME Metabolism
pathway KEGG Viral replication
pathway REACTOME Methylation
drug DRUGBANK Oxygen
disease MESH infertility
disease MESH obesity
disease MESH hyperglycemia
disease MESH RB1
disease MESH hereditary nonpolyposis colorectal cancer
disease MESH breast cancer
pathway KEGG Breast cancer
drug DRUGBANK Nandrolone phenpropionate
drug DRUGBANK Corticosterone
drug DRUGBANK (S)-Des-Me-Ampa
disease MESH Mas
drug DRUGBANK Naproxen
disease MESH Dis
disease MESH Arthritis
drug DRUGBANK Carboxyamidotriazole
drug DRUGBANK Testosterone
pathway KEGG Endocytosis
disease MESH Fed
drug DRUGBANK Histamine
disease MESH Escherichia coli Infection
drug DRUGBANK Isoxaflutole
disease MESH Mumps
disease MESH autism
disease MESH Park
disease MESH neurodevelopmental disorders
disease MESH Neuroinflammation
drug DRUGBANK Glycerol phenylbutyrate
drug DRUGBANK Trypsin
disease MESH influenza
drug DRUGBANK Hydroxyethyl Starch
drug DRUGBANK Dinoprostone
disease MESH Comas
drug DRUGBANK Glutathione
disease MESH GSH
drug DRUGBANK Silver
disease MESH respiratory syncytial virus infection
disease MESH Ito
disease MESH carcinogenesis
drug DRUGBANK Trihexyphenidyl
disease MESH sti
disease MESH cognitive dysfunction
disease MESH included

Original Article

(Visited 4 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *